Retinopathy of Prematurity and Glucose-6-Phosphate Dehydrogenase Activity: A Case-Control Study

Rajarajan Paulpandian1, Sourabh Dutta2, Reena Das3

  • 1Neonatology Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.

Insights

Higher glucose-6-phosphate dehydrogenase (G6PD) activity in red blood cells is linked to retinopathy of prematurity (ROP) in premature infants. Increased G6PD levels elevate the risk of developing ROP.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Ophthalmology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • The etiology of ROP is multifactorial, involving factors like prematurity, oxygen exposure, and birth weight.
  • Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme crucial for red blood cell function.

Purpose of the Study:

  • To investigate the association between red blood cell glucose-6-phosphate dehydrogenase (G6PD) activity and the occurrence of retinopathy of prematurity (ROP).
  • To determine if G6PD activity is an independent predictor of ROP in preterm infants.

Main Methods:

  • A case-control study was conducted in a Level-3 neonatal unit involving preterm infants (birth weight <2000g).
  • Sixty infants with ROP (cases) and sixty without ROP (controls) were enrolled, excluding transfusion recipients.
  • Quantitative assay of G6PD activity in red blood cells was performed as a candidate risk factor.

Main Results:

  • Infants with ROP exhibited higher median G6PD activity compared to controls.
  • G6PD activity showed a trend of increasing with ROP severity, being highest in ROP requiring treatment.
  • Multivariable logistic regression identified G6PD activity (Adjusted OR 1.14) and shorter gestation as independent predictors of ROP.

Conclusions:

  • Elevated red blood cell G6PD activity is independently associated with retinopathy of prematurity in preterm infants.
  • Each 1 U/g Hb increase in G6PD activity was associated with a 14% increased odds of ROP.
  • Severer forms of ROP correlate with higher G6PD activity levels, suggesting a potential role in ROP pathogenesis.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
207